Skip to main content
. 2019 Aug 29;10(22):5460–5468. doi: 10.7150/jca.35362

Figure 2.

Figure 2

Survival analysis of patients with varying levels of CALR expression in NPC. Kaplan-Meier estimated progression-free survival (PFS) and overall survival (OS) for NPC patients according to the expression levels of CALR protein in 81 NPC patients. P values were obtained by using the log-rank test. N, The number of cases; Events, the number of cases, who had recurrent tumor or died during the follow-up period.